F036-1275 Screening compound: N-[(E)-N-[2-(1H-INDOL-3-YL)ETHYL]-N'-(4-METHOXYPHENYL)CARBAMIMIDOYL]-4-(MORPHOLIN-4-YL)-4-OXOBUTANAMIDE

F036-1275 Screening compound: N-[(E)-N-[2-(1H-INDOL-3-YL)ETHYL]-N'-(4-METHOXYPHENYL)CARBAMIMIDOYL]-4-(MORPHOLIN-4-YL)-4-OXOBUTANAMIDE
F036-1275 Screening compound: N-[(E)-N-[2-(1H-INDOL-3-YL)ETHYL]-N'-(4-METHOXYPHENYL)CARBAMIMIDOYL]-4-(MORPHOLIN-4-YL)-4-OXOBUTANAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound F036-1275
N-[(E)-N-[2-(1H-INDOL-3-YL)ETHYL]-N'-(4-METHOXYPHENYL)CARBAMIMIDOYL]-4-(MORPHOLIN-4-YL)-4-OXOBUTANAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F036-1275

Molecular Formula

C26H31N5O4 (C26 H31 N5 O4)

Compound Name

N-[(E)-N-[2-(1H-INDOL-3-YL)ETHYL]-N'-(4-METHOXYPHENYL)CARBAMIMIDOYL]-4-(MORPHOLIN-4-YL)-4-OXOBUTANAMIDE

IUPAC name

n/a

SMILES

COc(cc1)ccc1/N=C(\NCCc1c[nH]c2c1cccc2)/NC(CCC(N1CCOCC1)=O)=O

InChI

InChI=1S/C26H31N5O4/c1-34-21-8-6-20(7-9-21)29-26(27-13-12-19-18-28-23-5-3-2-4-22(19)23)30-24(32)10-11-25(33)31-14-16-35-17-15-31/h2-9,18,28H,10-17H2,1H3,(H2,27,29,30,32)

InChI Key

DGXJQBDKMJZUHO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14937662

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.56

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.709

Distribution Coefficient, logD

1.648

Water Solubility, LogSw

-2.26

Polar Surface Area

83.195

Acid Dissociation Constant (pKa)

11.52

Base Dissociation Constant (pKb)

6.57

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

F036-1275 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F036-1275 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F036-1275?
Check Price and Availability of F036-1275, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F036-1275 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F036-1275
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F036-1275
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F036-1275 available by request